Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

AI and data science at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

22 organizations at SITC 2026 present work in AI, bioinformatics & data: 8 suppliers and service providers, 6 cancer centres and hospitals, 4 universities and research institutes, 2 government and non-profit bodies and 2 pharma and biotech companies. Between them they bring 14 presentations to the program. Most represented: U.S. Food and Drug Administration (8 on the program), National Cancer Institute (5 on the program), Icahn School of Medicine at Mount Sinai (4 on the program). 16 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–11 of 22 organizations

Organization	SITC 2026 Attendance
U.S. Food and Drug Administration Silver Spring, MD
fda.gov Government & non-profit U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.	Session Wed Nov 4 2:10pm–2:55pm Panel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics Encanto AB Regulatory Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Session Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Talk Fri Nov 6 2:45pm–3:00pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip From Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety Assessment 301A Regulatory · Models & tech
National Cancer Institute Bethesda, MD
cancer.gov Government & non-profit US federal agency for cancer research and training, part of the National Institutes of Health.	Session Thu Nov 5 12:00pm–1:30pm Careers Outside Academia and Industry – Careers in Policy, Advocacy and Non-Profit Organizations Encanto AB Talk Thu Nov 5 3:35pm–3:50pm Part of Session I – Grant Writing Essentials Considerations for Using AI Encanto AB Talk Thu Nov 5 2:35pm–2:45pm Part of Session I – Grant Writing Essentials Overview of NIH Grants Encanto AB Session Fri Nov 6 8:00am–8:05am Presidential Welcome Halls BC Session Fri Nov 6 3:55pm–5:30pm Oral Abstract Session 2 301D 3:55pm–5:25pm6 abstract presentations — titles not yet released Talk Sat Nov 7 6:02pm–6:20pm Part of Session 207b: AI-driven Protein Design to Enhance Cancer Immunotherapy T cell phenotype and protein structure-informed discovery of TCRs for cell therapy 301BC Cell therapy · AI & data Session Sun Nov 8 8:15am–9:40am Presidential Session Hall A 8:20am–9:20am4 abstract presentations — titles not yet released 9:20am–9:30amExpert DisucussantUniversity of Pittsburgh
Icahn School of Medicine at Mount Sinai New York, NY
icahn.mssm.edu Universities & research institutes Medical school of the Mount Sinai Health System in New York City.	Session Fri Nov 6 11:30am–12:15pm Clinical Oral Abstract Session Halls BC Clinical 11:30am–12:15pm3 abstract presentations — titles not yet released Session Sat Nov 7 5:20pm–6:40pm AI-driven Protein Design to Enhance Cancer Immunotherapy 301BC AI & data · New agents 5:26pm–5:44pmProtein Design to Improve Cell TherapiesTechnical University of Denmark 5:44pm–6:02pmDesigning protein-based hardwares for human immune systemMassachusetts Institute of Technology 6:02pm–6:20pmT cell phenotype and protein structure-informed discovery of TCRs for cell therapyNational Cancer Institute 6:20pm–6:40pm2 abstract presentations — titles not yet released Talk Sat Nov 7 6:20pm–6:40pm Part of Session 207c: Hot and Cold Tumors Hot and Cold Tumor Debate Hall A Tumor biology Session Sat Nov 7 5:20pm–6:40pm Hot and Cold Tumors Hall A Tumor biology 5:20pm–5:40pmWhat Is Meant By Hot And Cold Tumors?UCLA 5:40pm–6:00pmIdentifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-MapIcahn School of Medicine at Mount Sinai 6:00pm–6:20pm2 abstract presentations — titles not yet released 6:20pm–6:40pmHot and Cold Tumor DebateUCLA, Icahn School of Medicine at Mount Sinai, Brigham and Women's Hospital Talk Sat Nov 7 5:40pm–6:00pm Part of Session 207c: Hot and Cold Tumors Identifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-Map Hall A Tumor biology · AI & data Session Sat Nov 7 5:20pm–6:40pm Oral Abstract Session 4 301D 5:20pm–6:35pm5 abstract presentations — titles not yet released
Fred Hutchinson Cancer Center Seattle, WA
fredhutch.org Cancer centres & hospitals Cancer research and treatment center in Seattle, known for bone marrow transplantation and cellular immunotherapy.	Session Thu Nov 5 12:00pm–1:30pm Bioinformatics, Big Data, and AI (Table 2) Encanto AB AI & data Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Sat Nov 7 11:45am–12:05pm Part of Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Debate: Pros and Cons on Time of Day and Checkpoint Inhibitors Halls BC Clinical Talk Sat Nov 7 3:45pm–4:00pm Part of Session 206d: Novel Paradigms for Effectively Combining Immunotherapies with Radiopharmaceuticals or Radiation Therapy Distinct Immune Responses Induced by Different Forms of Radiotherapy Combined with Immune Checkpoint Inhibition 301BC Clinical
Massachusetts Institute of Technology Cambridge, MA
mit.edu Universities & research institutes Research university in Cambridge, Massachusetts.	Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Session Fri Nov 6 1:45pm–3:25pm Combination Therapies Involving Cell Therapy Halls BC Cell therapy 1:50pm–2:10pmCytokine Recipes for T cell immunotherapyStanford University 2:10pm–2:30pmCAR-Enhancers: Programmable Boosters for Durable Cell TherapyDana-Farber Cancer Institute 2:30pm–2:50pmRe-charging CAR T Cells Through Their TCR with Oncolytic Viruses.Mayo Clinic 2:50pm–3:20pm2 abstract presentations — titles not yet released Talk Fri Nov 6 5:00pm–5:30pm Part of Session 107b: Biotech Session: The Next Generation of Off-the-Shelf IO In Vivo - Ex Vivo Debate Halls BC Cell therapy Talk Sat Nov 7 5:44pm–6:02pm Part of Session 207b: AI-driven Protein Design to Enhance Cancer Immunotherapy Designing protein-based hardwares for human immune system 301BC AI & data · New agents
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program.	Booth Exhibiting at Booth 1228 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Talk Thu Nov 5 5:55pm–6:15pm Part of High-Impact Talks from Pharma Leaders Advancing External Innovation: Merck’s Oncology Strategy Regulatory Session Thu Nov 5 6:55pm–7:15pm Panel Session Fri Nov 6 3:55pm–5:30pm Biotech Session: The Next Generation of Off-the-Shelf IO Halls BC Cell therapy 3:55pm–4:10pmNext-gen T Cell Engagers 4:10pm–4:25pmIn vivo Cell Therapy Platforms for CancerEli Lilly and Company 4:25pm–4:40pmAllogeneic Cell TherapiesAllogene Therapeutics 4:40pm–5:00pm2 abstract presentations — titles not yet released 5:00pm–5:30pmIn Vivo - Ex Vivo DebateKite Pharma, Massachusetts Institute of Technology, Roswell Park Comprehensive Cancer Center, Azalea Therapeutics
Case Western Reserve University Cleveland, OH
case.edu Universities & research institutes Private research university in Cleveland with a school of medicine.	Session Thu Nov 5 12:00pm–1:30pm Bioinformatics, Big Data, and AI (Table 1) Encanto AB AI & data Session Fri Nov 6 1:45pm–3:25pm Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip 301A Models & tech 2:00pm–2:15pmPatient-Derived Brain Tumor Organoids to Model and Overcome Myeloid ImmunosuppressionCase Western Reserve University 2:15pm–2:30pmPersonalizing Cancer Immunotherapy Using Patient-Derived Tumor ModelsNetherlands Cancer Institute 2:30pm–2:45pmDynamic Immune Profiling Using Human Ex Vivo Tumor ModelsDana-Farber Cancer Institute 2:45pm–3:00pmFrom Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety AssessmentU.S. Food and Drug Administration 3:00pm–3:20pm2 abstract presentations — titles not yet released Talk Fri Nov 6 2:00pm–2:15pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Patient-Derived Brain Tumor Organoids to Model and Overcome Myeloid Immunosuppression 301A Models & tech · Tumor biology
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company with an oncology portfolio that includes antibody-drug conjugates from its Seagen acquisition.	Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics 2:55pm–3:10pmNetworking Break 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI 3:55pm–4:10pmNetworking Break #2 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents 4:55pm–5:00pmClosing Remarks Workshop Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data
Boston Children's Hospital Boston, MA
childrenshospital.org Cancer centres & hospitals Pediatric academic medical center in Boston and a teaching hospital of Harvard Medical School.	Session Sat Nov 7 5:20pm–6:40pm AI-driven Protein Design to Enhance Cancer Immunotherapy 301BC AI & data · New agents 5:26pm–5:44pmProtein Design to Improve Cell TherapiesTechnical University of Denmark 5:44pm–6:02pmDesigning protein-based hardwares for human immune systemMassachusetts Institute of Technology 6:02pm–6:20pmT cell phenotype and protein structure-informed discovery of TCRs for cell therapyNational Cancer Institute 6:20pm–6:40pm2 abstract presentations — titles not yet released
Lausanne University Hospital (CHUV) Lausanne, Switzerland
chuv.ch Cancer centres & hospitals Swiss university hospital affiliated with the University of Lausanne.	Session Fri Nov 6 3:55pm–5:30pm Monitoring and Predicting Responses (AI, radiomics and other modalities) 301A Biomarkers · AI & data 3:55pm–4:35pm2 abstract presentations — titles not yet released
Providence Genomics Portland, OR
genomics.providence.org Cancer centres & hospitals Clinical genomics laboratory and research program of the Providence health system, profiling tumors for patient care and research.	Talk Sat Nov 7 10:20am–10:40am Part of Session 202: Spatial Biology Computational Spatial Biology and AI-assisted Interpretation Halls BC AI & data · Models & tech